LAUSR

Neoadjuvant target therapy with ensartinib in lung adenocarcinoma with EML4-ALK fusion variant: a case report and literature review.

Sign Up to like & get
recommendations!
0 Published in 2022 at "Anti-cancer drugs"

DOI: 10.1097/cad.0000000000001432

Abstract: Although neoadjuvant target therapy has been used to treat patients with non-small-cell lung cancer (NSCLC), most of these patients have mutations in the epidermal growth factor receptor (EGFR) gene. Few patients to date have received… read more here.

Keywords: lung; target therapy; alk; neoadjuvant target ... See more keywords